These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 6140271

  • 1. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ, Ensinck JW.
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [Abstract] [Full Text] [Related]

  • 2. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
    Ahrén B, Veith RC, Paquette TL, Taborsky GJ.
    Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
    [Abstract] [Full Text] [Related]

  • 3. Calcitonin gene-related peptide: a potent and selective stimulator of gastrointestinal somatostatin secretion.
    Dunning BE, Taborsky GJ.
    Endocrinology; 1987 May; 120(5):1774-81. PubMed ID: 2882997
    [Abstract] [Full Text] [Related]

  • 4. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K, Harding PE, Chou M, Mashiter GD, Stout J, Diamond D, Field JB.
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [Abstract] [Full Text] [Related]

  • 5. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
    Marre M, Miller J, Helman AM, Assan R.
    Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
    [Abstract] [Full Text] [Related]

  • 6. Galanin release during pancreatic nerve stimulation is sufficient to influence islet function.
    Dunning BE, Taborsky GJ.
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E191-8. PubMed ID: 2463765
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M, Kronheim S, Pimstone B, Shapiro B.
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin-28 does not regulate islet function in the dog.
    Klaff LJ, Dunning BE, Taborsky GJ.
    Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T, Howard B, Dobbs RE, Unger RH.
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [Abstract] [Full Text] [Related]

  • 10. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T, Dobbs RE, Harris V, Unger RH.
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [Abstract] [Full Text] [Related]

  • 11. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V, Zyznar E, Rouiller D, Harris V, Unger RH.
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger R.
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [Abstract] [Full Text] [Related]

  • 13. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K, Unger RH.
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [Abstract] [Full Text] [Related]

  • 14. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V, Lawecki J, Ditschuneit HH, Lukas B, Maier V, Pfeiffer EF.
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [Abstract] [Full Text] [Related]

  • 15. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V, Rouiller D, Harris V, Unger RH.
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH, Ohneda A, Valverde I, Eisentraut AM, Exton J.
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [Abstract] [Full Text] [Related]

  • 17. Effect of acetylcholine on the release of pancreatic and gastric somatostatin-like immunoreactivity in normal, chemically sympathectomized and indomethacin-treated dogs.
    Schusdziarra V, Stapelfeldt W, Klier M, Pfeiffer EF.
    Hepatogastroenterology; 1982 Aug; 29(4):153-6. PubMed ID: 6127302
    [Abstract] [Full Text] [Related]

  • 18. Effects of E coli endotoxin on pancreatic hormones and blood flow.
    Spitzer JJ, Ferguson JL, Hirsch HJ, Loo S, Gabbay KH.
    Circ Shock; 1980 Aug; 7(4):353-60. PubMed ID: 6112073
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D, Strosser MT, Mialhe P.
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [Abstract] [Full Text] [Related]

  • 20. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T, Shimoda S, Nishida K, Matsuo Y, Ichimori S, Ichinose K, Shichiri M, Sakakida M, Araki E.
    J Artif Organs; 2004 Nov; 7(2):91-100. PubMed ID: 15309676
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.